AOD-9604 (Research-Grade Lyophilized Peptide)
For Laboratory Use Only – Not for Human or Veterinary Application
Product Overview
AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (HGH), encompassing amino acids 176–191. This analog is studied in controlled laboratory settings for its role in lipid metabolism and selective lipolytic pathways, distinct from the anabolic effects linked to native HGH.
Supplied as a lyophilized powder in sterile vials, AOD-9604 is intended solely for in vitro experimentation and non-clinical research use.
Scientific Classification
Attribute | Detail |
---|---|
Peptide Class | Modified HGH fragment (176–191) |
Sequence | Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe |
Purity | ≥98% (HPLC-verified) |
Form | Lyophilized powder in sterile vial |
Solubility | Reconstitutes in bacteriostatic water (for research handling only) |
Storage | ≤–20 °C for long-term storage; refrigerate after reconstitution |
Available Quantities
- 1.5 mg sterile vial
- 2 mg sterile vial
- 5 mg sterile vial
- Bulk packaging: 10 × 1.5 mg vials (for qualified institutional accounts)
Primary Areas of Research
AOD-9604 has been explored in laboratory models studying:
- Lipolysis Mechanisms
- Beta-oxidation pathways in adipose cell cultures
- Fat mobilization without elevating IGF-1 levels
- Selective Non-Anabolic Activity
- Does not bind to growth hormone receptors
- No proliferative effects on cartilage or skeletal tissues
- Adipocyte Differentiation & Fat Mass Studies
- In vitro models assessing white adipocyte formation
- Combination protocols with mitochondrial metabolism modulators
- Glucose Homeostasis & Insulin Sensitivity Models
- Research into AMPK pathway involvement
- Exploratory preclinical models in insulin-resistant rodents
All findings remain preliminary and applicable solely within laboratory research contexts.
Research-Specific Highlights
- Suitable for longitudinal adipose tissue studies
- Commonly co-investigated with compounds like 5-Amino-1MQ, L-Carnitine, and CJC-1295
- Referenced in preclinical literature in endocrinology and metabolic research fields
Handling & Use
- Reconstitution requires aseptic technique
- Reconstituted solution stable for up to 30 days when refrigerated (2–8 °C)
- Avoid repeated freeze-thaw cycles to preserve integrity
- Supplied as lyophilized powder only—diluents, needles, or consumables not included
Regulatory and Compliance Notice
- Research Use Only: For qualified laboratory personnel exclusively.
- Not FDA Approved: No medical, diagnostic, or therapeutic claims are made.
- Not for Human or Veterinary Use: Do not inject, ingest, or administer to humans or animals.
- Qualified Handling: Must be handled under approved laboratory protocols.
Quality Assurance
HVY Research manufactures AOD-9604 under controlled sterile conditions, ensuring batch consistency and identity verification. Research use requires adherence to institutional safety protocols, including the use of personal protective equipment (PPE).
Disclaimer
This product is intended strictly for research purposes. It is not approved for therapeutic, diagnostic, or clinical applications and is not intended for human or veterinary consumption. Information provided is for scientific reference only.
There are no reviews yet.